$19.07
4.89% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US8292141053
Symbol
SLP

Simulations Plus, Inc. Stock price

$19.07
-12.03 38.68% 1M
-11.86 38.34% 6M
-8.82 31.62% YTD
-29.55 60.78% 1Y
-35.52 65.07% 5Y
+12.77 202.70% 10Y
+18.19 2,054.80% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.98 4.89%
ISIN
US8292141053
Symbol
SLP

Key metrics

Market capitalization $403.23m
Enterprise Value $381.84m
P/E (TTM) P/E ratio 55.69
EV/FCF (TTM) EV/FCF 46.45
EV/Sales (TTM) EV/Sales 4.86
P/S ratio (TTM) P/S ratio 5.13
P/B ratio (TTM) P/B ratio 2.13
Dividend yield 1.20%
Last dividend (FY24) $0.24
Revenue growth (TTM) Revenue growth 21.48%
Revenue (TTM) Revenue $78.56m
EBIT (operating result TTM) EBIT $3.57m
Free Cash Flow (TTM) Free Cash Flow $8.22m
Cash position $21.39m
EPS (TTM) EPS $0.36
P/E forward 54.93
P/S forward 4.67
EV/Sales forward 4.42
Short interest 17.87%
Show more

Is Simulations Plus, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Simulations Plus, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Simulations Plus, Inc. forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Simulations Plus, Inc. forecast:

Buy
83%
Hold
17%

Financial data from Simulations Plus, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Feb '25
+/-
%
79 79
21% 21%
100%
- Direct Costs 35 35
119% 119%
45%
43 43
11% 11%
55%
- Selling and Administrative Expenses 33 33
6% 6%
42%
- Research and Development Expense 7.22 7.22
58% 58%
9%
12 12
14% 14%
15%
- Depreciation and Amortization 8.01 8.01
92% 92%
10%
EBIT (Operating Income) EBIT 3.57 3.57
61% 61%
5%
Net Profit 7.26 7.26
31% 31%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Simulations Plus, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Simulations Plus, Inc. Stock News

Negative
Seeking Alpha
about 12 hours ago
Simulations Plus' Q3 FY25 results missed expectations, with revenue guidance cut sharply due to biopharma market weakness and services segment volatility. Organic growth continues to decelerate and the company's margins are under pressure. This situation is likely to persist, while the demand environment is soft. Simulations Plus' revenue multiple remains high, given its dependence on services ...
Neutral
Business Wire
one day ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O'Connor, Chief Executive Officer, will be participating in the Citizens Medical Devices a...
Neutral
Business Wire
2 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue gui...
More Simulations Plus, Inc. News

Company Profile

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Head office United States
CEO Mr. O'Connor
Employees 245
Founded 1996
Website www.simulations-plus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today